Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Fentanyl
Breakyl
Not routinely available
SMC (947/13)
13/01/2014
Indication
Treatment of breakthrough pain (BTP) in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.
Therapeutic Area
Central nervous system
Status Description
Not routinely available as not recommended for use in NHSScotland
Formulation
200mcg, 400mcg and 800mcg buccal film
Comments
None
Link to Advice
Advice Published
13/01/2014
SMC Submission Type
Non submission
SMC Status
Not recommended